Cargando…
Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol
The outbreak of the coronavirus 2 disease 2019 (COVID-19) puts an enormous burden on healthcare systems worldwide. This may worsen outcomes in patients with severe chronic diseases such as cancer, autoimmune diseases, and immune deficiencies. In this critical situation, only a few available data exi...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215159/ https://www.ncbi.nlm.nih.gov/pubmed/35756683 http://dx.doi.org/10.3389/fonc.2022.828660 |
_version_ | 1784731156867973120 |
---|---|
author | Silvestris, Nicola Belleudi, Valeria Addis, Antonio Pimpinelli, Fulvia Morrone, Aldo Sciacchitano, Salvatore Mancini, Rita Garrisi, Vito Michele Costantini, Massimo Ciliberto, Gennaro Frisardi, Vincenza Piaggio, Giulia |
author_facet | Silvestris, Nicola Belleudi, Valeria Addis, Antonio Pimpinelli, Fulvia Morrone, Aldo Sciacchitano, Salvatore Mancini, Rita Garrisi, Vito Michele Costantini, Massimo Ciliberto, Gennaro Frisardi, Vincenza Piaggio, Giulia |
author_sort | Silvestris, Nicola |
collection | PubMed |
description | The outbreak of the coronavirus 2 disease 2019 (COVID-19) puts an enormous burden on healthcare systems worldwide. This may worsen outcomes in patients with severe chronic diseases such as cancer, autoimmune diseases, and immune deficiencies. In this critical situation, only a few available data exist, which do not allow us to provide practical guides for the treatment of oncological or immunocompromised patients. Therefore, a further step forward is needed, addressing the specific needs and demands of frail patients in the pandemic era. Here we aim to present a protocol of a study approved by an ethical committee named “CO.M.E.TA”. CO.M.E.TA protocol is a network project involving six Italian institutions and its goals are: i) to measure and compare the impact of the pandemic on the access of cancer and immunocompromised patients to therapies in three Italian regions; ii) to assess how reorganizational measures put in place in these different institutions have impacted specific metrics of performance; iii) to establish a COVID-19 Biobank of biological samples from SARS-CoV-2 infected patients to be used to study immunological alterations in patients with immune frailty. |
format | Online Article Text |
id | pubmed-9215159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92151592022-06-23 Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol Silvestris, Nicola Belleudi, Valeria Addis, Antonio Pimpinelli, Fulvia Morrone, Aldo Sciacchitano, Salvatore Mancini, Rita Garrisi, Vito Michele Costantini, Massimo Ciliberto, Gennaro Frisardi, Vincenza Piaggio, Giulia Front Oncol Oncology The outbreak of the coronavirus 2 disease 2019 (COVID-19) puts an enormous burden on healthcare systems worldwide. This may worsen outcomes in patients with severe chronic diseases such as cancer, autoimmune diseases, and immune deficiencies. In this critical situation, only a few available data exist, which do not allow us to provide practical guides for the treatment of oncological or immunocompromised patients. Therefore, a further step forward is needed, addressing the specific needs and demands of frail patients in the pandemic era. Here we aim to present a protocol of a study approved by an ethical committee named “CO.M.E.TA”. CO.M.E.TA protocol is a network project involving six Italian institutions and its goals are: i) to measure and compare the impact of the pandemic on the access of cancer and immunocompromised patients to therapies in three Italian regions; ii) to assess how reorganizational measures put in place in these different institutions have impacted specific metrics of performance; iii) to establish a COVID-19 Biobank of biological samples from SARS-CoV-2 infected patients to be used to study immunological alterations in patients with immune frailty. Frontiers Media S.A. 2022-06-02 /pmc/articles/PMC9215159/ /pubmed/35756683 http://dx.doi.org/10.3389/fonc.2022.828660 Text en Copyright © 2022 Silvestris, Belleudi, Addis, Pimpinelli, Morrone, Sciacchitano, Mancini, Garrisi, Costantini, Ciliberto, Frisardi and Piaggio https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Silvestris, Nicola Belleudi, Valeria Addis, Antonio Pimpinelli, Fulvia Morrone, Aldo Sciacchitano, Salvatore Mancini, Rita Garrisi, Vito Michele Costantini, Massimo Ciliberto, Gennaro Frisardi, Vincenza Piaggio, Giulia Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol |
title | Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol |
title_full | Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol |
title_fullStr | Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol |
title_full_unstemmed | Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol |
title_short | Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol |
title_sort | development of approaches and metrics to measure the impact and improve the clinical outcomes of patients with frailty in the era of covid-19. the cometa italian protocol |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215159/ https://www.ncbi.nlm.nih.gov/pubmed/35756683 http://dx.doi.org/10.3389/fonc.2022.828660 |
work_keys_str_mv | AT silvestrisnicola developmentofapproachesandmetricstomeasuretheimpactandimprovetheclinicaloutcomesofpatientswithfrailtyintheeraofcovid19thecometaitalianprotocol AT belleudivaleria developmentofapproachesandmetricstomeasuretheimpactandimprovetheclinicaloutcomesofpatientswithfrailtyintheeraofcovid19thecometaitalianprotocol AT addisantonio developmentofapproachesandmetricstomeasuretheimpactandimprovetheclinicaloutcomesofpatientswithfrailtyintheeraofcovid19thecometaitalianprotocol AT pimpinellifulvia developmentofapproachesandmetricstomeasuretheimpactandimprovetheclinicaloutcomesofpatientswithfrailtyintheeraofcovid19thecometaitalianprotocol AT morronealdo developmentofapproachesandmetricstomeasuretheimpactandimprovetheclinicaloutcomesofpatientswithfrailtyintheeraofcovid19thecometaitalianprotocol AT sciacchitanosalvatore developmentofapproachesandmetricstomeasuretheimpactandimprovetheclinicaloutcomesofpatientswithfrailtyintheeraofcovid19thecometaitalianprotocol AT mancinirita developmentofapproachesandmetricstomeasuretheimpactandimprovetheclinicaloutcomesofpatientswithfrailtyintheeraofcovid19thecometaitalianprotocol AT garrisivitomichele developmentofapproachesandmetricstomeasuretheimpactandimprovetheclinicaloutcomesofpatientswithfrailtyintheeraofcovid19thecometaitalianprotocol AT costantinimassimo developmentofapproachesandmetricstomeasuretheimpactandimprovetheclinicaloutcomesofpatientswithfrailtyintheeraofcovid19thecometaitalianprotocol AT cilibertogennaro developmentofapproachesandmetricstomeasuretheimpactandimprovetheclinicaloutcomesofpatientswithfrailtyintheeraofcovid19thecometaitalianprotocol AT frisardivincenza developmentofapproachesandmetricstomeasuretheimpactandimprovetheclinicaloutcomesofpatientswithfrailtyintheeraofcovid19thecometaitalianprotocol AT piaggiogiulia developmentofapproachesandmetricstomeasuretheimpactandimprovetheclinicaloutcomesofpatientswithfrailtyintheeraofcovid19thecometaitalianprotocol |